Erectile Dysfunction Completed Phase 2 Trials for Botulinum toxin type A (DB00083)

Also known as: EDS / ED / Erectile difficulties / Erectile Dysfunction (ED) / Difficulty maintaining an erection / Decreased erections / Male Erectile Disorder / Male Erectile Dysfunction / Difficult erection / Inability to achieve or maintain erection / Erectile Dysfunctions / Male erectile dysfunction, unspecified / Erectile dysfunction (disorder) / Impotence / Erectile dysfunction NOS / Impotent / Erectile disturbance / Erection failure / Psychogenic impotence

IndicationStatusPhase
DBCOND0029956 (Erectile Dysfunction)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03355963Intracavernosal Injection of Botulinum Toxin Type A (50 and 100 Unit) in the Treatment of Erectile DysfunctionTreatment